Oxford Financial Group’s Elanco Animal Health ELAN Stock Holding History

Oxford Financial Group’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-10,219	Closed	-$166K	–	324
2024 Q1	$166K	Hold	10,219	–	–	0.01%	221
2023 Q4	$152K	Hold	10,219	–	–	0.01%	236
2023 Q3	$115K	Hold	10,219	–	–	0.01%	226
2023 Q2	$103K	Hold	10,219	–	–	0.01%	244
2023 Q1	$96.1K	Hold	10,219	–	–	0.01%	205
2022 Q4	$125K	Hold	10,219	–	–	0.01%	194
2022 Q3	$127K	Sell	10,219 -5	-0%	-$87	0.02%	175
2022 Q2	$201K	Buy	10,224 +5	+0%	+$118	0.03%	183
2022 Q1	$267K	Hold	10,219	–	–	0.03%	166
2021 Q4	$290K	Hold	10,219	–	–	0.03%	166
2021 Q3	$326K	Hold	10,219	–	–	0.04%	143
2021 Q2	$354K	Hold	10,219	–	–	0.05%	134
2021 Q1	$301K	Sell	10,219 -5,396	-35%	-$166K	0.04%	143
2020 Q4	$479K	Buy	15,615 +6,538	+72%	+$199K	0.07%	102
2020 Q3	$254K	Buy	+9,077	New	+$230K	0.04%	141
2020 Q2	–	Sell	-9,077	Closed	-$203K	–	192
2020 Q1	$203K	Buy	+9,077	New	+$249K	0.04%	150

Other funds holding ELAN

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.78B AUM 5.83% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Oxford Financial Group's ELAN Position: Q2 2024 in Review

Oxford Financial Group sold out of Elanco Animal Health (ELAN) in Q2 2024, closing a stake of 10,219 shares — an estimated $166K sold.

Oxford Financial Group first reported a position in ELAN in Q1 2020 and held it in 16 quarters. The position peaked at $479K in Q4 2020. 402 funds tracked by Wall St. Rank hold ELAN as of Q2 2024.

Oxford Financial Group reported no remaining Elanco Animal Health position as of Q2 2024 after selling out during the quarter.
Oxford Financial Group sold 10,219 Elanco Animal Health shares in Q2 2024, an estimated $166K.
Oxford Financial Group first reported a position in Elanco Animal Health in Q1 2020 and held it in 16 quarters.
Oxford Financial Group's Elanco Animal Health position peaked at $479K in Q4 2020.
402 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2024.

Based on Oxford Financial Group's 13F filing for Q2 2024, filed 14 Aug 2024.